Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Isoniazid 50mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 50mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Rifampicin+isoniazid 150mg/100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid- and rifampicin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing isoniazid and pyrazinamide and rifampicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrazide antituberculosis drug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 50mg/5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 150 mg and rifampicin 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isoniazid 100mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethambutol HCl+isoniazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Eltrombopag (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenelzine |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isocarboxazid (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrazine sulfate |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benserazide - chemical (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrazide antituberculosis agent |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iproniazid (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pasiniazid |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
1,2-diphenylhydrazine (substance) |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrazine sulfate |
Is modification of (attribute) |
True |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydralazine |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydralazine hydrochloride |
Is a |
False |
Hydrazine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|